| Project/Area Number |
15K18992
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
General pharmacology
|
|---|
| Research Institution | Sapporo Medical University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2015-04-01 – 2017-03-31
|
| Project Status |
Completed (Fiscal Year 2016)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Keywords | マイトファジー / SIRT1 / オートファジー |
|---|
| Outline of Final Research Achievements |
We found skeletal muscle dysfunction and impaired activation autophagy in skeletal muscle-specific SIRT1 knockout mice. These suggest that SIRT1 in skeletal muscle cells plays an important role in maintaining skeletal muscle function via autophagy. In myoblasts, resveratrol (RSV), a SIRT1 activator, promoted mitophagy. Mitochondrial reactive oxygen species (ROS) levels induced by antimycin A were significantly reduced by RSV. This effect of RSV was blocked by knockdown of PINK-1 which triggers mitophagy, suggesting that SIRT1 activation decrease mitochondrial ROS levels via mitophagy. We demonstrate using in vivo and in vitro models the relationship between SIRT1 and autophagy/mitophagy and its significance in skeletal muscle protection.
|
